LAMC2 and esophageal squamous cell carcinoma: Additionally, lactylation modification of histone H3K9 (H3K9la) acts as an activating epigenetic mark, facilitating the recruitment of transcriptional coactivators to the LAMC2 promoter and thereby enhancing the proliferation and migration capabilities of esophageal squamous cell carcinoma (33).